Rongrong Cui - State Key Lab Drug Res, Shanghai Inst Mat Med

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 39 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Design, Synthesis, and Structure-Activity Relationship Studies of Triazolo-Pyrimidine Derivatives As WRN Inhibitors for the Treatment of MSI Tumors

Qibang Sui,Yuanyang Zhou, Manjia Li,Dan Wang,Rongrong Cui, Xiaoying Cai,Jia Liu, Xiaofeng Wang, Dan Teng,Jingyi Zhou,Hui Hou,Sulin Zhang,Mingyue Zheng

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2025)

Cited0Views0WOSBibtex

Discovery of 3-(Fluoro-imidazolyl)pyridazine Derivatives As Potent STING Agonists with Antitumor Activity

Hui Hou, Jingyi Zhou, Qibang Sui, Changfa Zhang, Zhaoming Su,Rongrong Cui,Bin Shan, Peijia Xu, Zhengyang Chen, Bing Jiang, Manjia Li, Keke Zhang, Yajie Wang, Ning Ma, Dan Teng,Mingyue Zheng,Sulin Zhang

Journal of medicinal chemistryno. 10 (2025): 9864-9885

Cited0Views0WOSBibtex

Transfer Learning Enhanced Graph Neural Network for Aldehyde Oxidase Metabolism Prediction and Its Experimental Application

Jiacheng Xiong,Rongrong Cui,Zhaojun Li,Wei Zhang,Runze Zhang,Zunyun Fu, Xiaohong Liu, Zhenghao Li,Kaixian Chen,Mingyue Zheng

ACTA PHARMACEUTICA SINICA B（2024）

Cited1Views0WOSBibtex

Design, Synthesis, and Biological Evaluation of Potent and Selective PROTAC Degraders of Oncogenic KRASG12D

Chuan Zhou,Zisheng Fan,Yuejiao Gu, Zhiming Ge, Zhaofan Tao,Rongrong Cui,Yupeng Li,Guizhen Zhou,Ruifeng Huo,Mingshan Gao,Dan Wang, Wei He,Mingyue Zheng,Sulin Zhang,Tianfeng Xu

Journal of Medicinal Chemistryno. 2 (2024): 1147-1167

Cited6Views0WOSBibtex

Targeting JMJD1C to Selectively Disrupt Tumor Treg Cell Fitness Enhances Antitumor Immunity

Xuehui Long,Sulin Zhang,Yuliang Wang,Jingjing Chen,Yanlai Lu,Hui Hou, Bichun Lin,Xutong Li,Chang Shen,Ruirui Yang,Huamin Zhu,Rongrong Cui,Duanhua Cao,Geng Chen,Dan Wang,Yun Chen,Sulan Zhai, Zhiqin Zeng,Shusheng Wu, Mengting Lou, Junhong Chen,Jian Zou,Mingyue Zheng,Jun Qin,Xiaoming Wang

Nature Immunology（2024）

Cited10Views0WOSNATUREBibtex

Discovery of Imidazo[1,2-a]pyrazine Derivatives As Potent ENPP1 Inhibitors

Shiping Zhan,Yingying Zhang, Tian Cao,Ruirui Yang,Qiang Wang,Lin Huang,Rongrong Cui,Jie Yu,Haifang Meng, Yitian Wang,Sulin Zhang,Mingyue Zheng,Xiaowei Wu

JOURNAL OF MEDICINAL CHEMISTRY（2024）

Cited0Views0WOSBibtex

Sequence-based Drug Design As a Concept in Computational Drug Design

Nature Communicationsno. 1 (2023)

Cited35Views0WOSNATUREBibtex

Discovery of a Potent, Cooperative, and Selective SOS1 PROTAC ZZ151 with in Vivo Antitumor Efficacy in KRAS-Mutant Cancers

Zehui Zhou,Guizhen Zhou,Chuan Zhou,Zisheng Fan,Rongrong Cui,Yupeng Li,Rui Li,Yuejiao Gu,Huajie Li, Zhiming Ge,Xiaojia Cai,Bing Jiang,Dan Wang,Mingyue Zheng,Tianfeng Xu,Sulin Zhang

Journal of Medicinal Chemistryno. 6 (2023): 4197-4214

Cited18Views0WOSBibtex

Discovery of the First-in-Class Agonist-Based SOS1 PROTACs Effective in Human Cancer Cells Harboring Various KRAS Mutations

Chuan Zhou,Zisheng Fan,Zehui Zhou,Yupeng Li,Rongrong Cui,Chaoyi Liu,Guizhen Zhou,Xingxing Diao,Hualiang Jiang,Mingyue Zheng,Sulin Zhang,Tianfeng Xu

Journal of Medicinal Chemistry（2022）

Cited49Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn